Journals / Uluslararası Hematoloji-Onkoloji Dergisi / 2018 / Cilt: 28 - Sayı: 1

Akciğer Kanserli Hastalarda İzlem Sürecindeki Değişikliklerin Yaşam Kalitesine Etkisinin EQ-5D Ölçeği ve Takip Sonuçları ile Değerlendirilmesi (AKAYAK-1 Çok Merkezli Proje)

The Assessment of the Effect of Changes in Lung Cancer Follow-up Period on the Quality of Life Using EQ-5D Questionnaire and Follow Data (AKAYAK-1 Multicenter Project)

Pages
1–10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The psychometric properties of the Turkish version of the EQ-5D questionnaire is a valid and reliable scale for patients with lung cancer in Turkey and it can be safely used in clinical practices

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The EURO-QOL (EQ-5D), a generic quality of life measure, is a self-report scale.
📊
Key Findings & Data:The aim was to study the reliability, validity and feasibility of the Turkish version of the EQ-5D as an instrument to evaluate quality of life in lung cancer patients in Turkish society.
💡
Conclusion & Impact:The psychometric properties of the Turkish version of the EQ-5D questionnaire is a valid and reliable scale for patients with lung cancer in Turkey and it can be safely used in clinical practices
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The EURO-QOL (EQ-5D), a generic quality of life measure, is a self-report scale. The aim was to study the reliability, validity and feasibility of the Turkish version of the EQ-5D as an instrument to evaluate quality of life in lung cancer patients in Turkish society. A prospective cohort study carried out within the framework of the multicenter Lung Cancer Association Project which was conducted in collaboration with Turkish Thoracic Society, Lung and Pleural Malignancies working group and Health and Quality of Life Society. A total of 266 patients were included in the study with a mean age of 61.3 years. 75,9% of the patients had chemotherapy alone; 9% received sequential chemotherapy and radiotherapy, 8,6% were given concurrent chemotherapy and radiotherapy, and 6,4% of them received radical radiotherapy alone. EQ-5D score measures at the moment of diagnosis were found to be moderately reliable while measures at the 3rd chemotherapy cycle, 5th chemotherapy cycle and after the radiotherapy were highly reliable. The items of the EQ-5D were found to be consistent among themselves. EQ-5D Visual Analogue Scale scores at diagnosis, the 3rd cycle, the 5th cycle and following radiotherapy were assessed to be correlated with each other. EQ-5D scale was found to be valid as it meets the conditions of 6 fit indices in our study design. The psychometric properties of the Turkish version of the EQ-5D questionnaire is a valid and reliable scale for patients with lung cancer in Turkey and it can be safely used in clinical practices

Özet

Akciğer Kanserli Hastalarda İzlem Sürecindeki Değişikliklerin Yaşam Kalitesine Etkisinin EQ-5D Ölçeği ve Takip Sonuçları ile Değerlendirilmesi (AKAYAK-1 Çok Merkezli Proje)EURO-QOL (EQ-5D) genel yaşam kalitesi ölçeği bir öz-bildirim ölçeğidir. Amaç Türk toplumunda akciğer kanserinde yaşam kalitesi değerlendirme aracı olarak EQ-5D'nin Türkçe sürümünün güvenilir, geçerli ve uygulanabilir olup olmadığının araştırılmasıdır. Türk Toraks Derneği, Akciğer ve Plevra Maligniteleri Çalışma Grubu ile Sağlıkta Yaşam Kalitesi Derneğinin ortaklaşa yürüttüğü çok merkezli Akciğer Kanserinde Yaşam Kalitesi Projesi çerçevesinde yürütülen prospektif bir kohort çalışmasıdır. Çalışmaya yaş ortalaması 61.3 yıl olan 266 hasta alındı. Hastaların %75,9'u sadece kemoterapi; %9'u ardışık kemoterapi ve radyoterapi, %8,6'sı eşzamanlı kemoterapi ve radyoterapi, %6,4'ü sadece radikal radyoterapi almıştır. Tanı anındaki EQ-5D indeks skor ölçümünün orta derecede güvenilir, 3. kemoterapi küründeki ölçüm, 5. kemoterapi küründeki ölçüm ve radyoterapi sonrasındaki ölçümlerin yüksek derecede güvenilir olduğu bulunmuştur. EQ-5D maddelerinin kendi içinde tutarlı olduğu görülmüştür. EQ-5D Vizuel Analog Skalası tanı anında, 3. kürde, 5. kürde ve radyoterapi sonrası değerlendirildiğinde birbiri ile korele bulunmuştur. Çalışma modelimizde 6 tane uyum indeksi koşulları yerine getirdiğinden EQ-5D ölçeği geçerli bulunmuştur. EQ-5D genel yaşam kalitesi ölçeğinin Türkçe sürümünün psikometrik özellikleri, Türkiye'deki akciğer kanserli hastalarda geçerli ve güvenilir bir ölçektir ve klinik pratikte güvenle kullanılabilir

🔖

Cite This Article

ERBAYCU, A. E., GÖKSEL, T., ESER, E., GURSUL, K. K., BAŞARIK, B., OZ, A., ÇELİK, P., EDIZ, E. C., HATİPOĞLU, O., YAYLA, B. A., BAŞER, S., BAYDUR, H. (2018). Akciğer Kanserli Hastalarda İzlem Sürecindeki Değişikliklerin Yaşam Kalitesine Etkisinin EQ-5D Ölçeği ve Takip Sonuçları ile Değerlendirilmesi (AKAYAK-1 Çok Merkezli Proje). Uluslararası Hematoloji-Onkoloji Dergisi, Cilt: 28 - Sayı: 1, 1–10. https://ajindex.com/articles/323257

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. The WHOQOL Group. The development of the World Health Organisation quality of life assessment instrument (the WHOQOL). In: Quality of Life Assessment: International Perspectives. Orley J, Kuyken W (eds). Springer Verlag, Heidelberg, 1994: 41-57
  2. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 46: 1569-85, 1998
  3. Stucki G, Kroeling P. Principles of rehabilitation. In: Rheumatology. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds). Mosby, Toronto, 2003: 517-530
  4. Juniper EF. How important is quality of life in pediatric asthma? Pediatr Pulmonol 15: 17-21, 1997
  5. Fries J, Singh G. The Hierarchy Of Patient Outcomes. Quality of Life and Pharmacoeconomics. In: Clinical Trials. 2nd edition. Lippincott-Raven Publishers, Philadelphia, 1996: 33
  6. Eser S, Göksel T, Erbaycu AE, et al. Comparison of generic and lung cancer-specific quality of life instruments for predictive ability of survival in patients with advanced lung cancer. Springerplus 5: 1833, 2016
  7. Drummond MF, O’Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. York, Oxford University Press, 1997: 221-224
  8. Dolan P, Gudex C, Kind P, Williams A. The time trade-off method: results from a general population study. Health Econ 5: 141-154, 1996
  9. Pickard AS, Neary MP, Cella D. Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual Life Outcomes 21: 70, 2007
  10. Kim SH, Kim HJ, Lee SI, Jo MW. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Qual Life Res 21: 1065-1073, 2012
  11. Grutters JP, Joore MA, Wiegman EM, et al. Health-related quality of life in patients surviving non-small cell lung cancer. Thorax 65: 903-7, 2010
  12. Doyle S, Lloyd A, Walker M. Health state utility scores in advanced non-small cell lung cancer. Lung Cancer 62: 374- 380, 2008
  13. Belani CP, Pereira JR, von Pawel J, et al. TAX 326 study group: Effect of chemotherapy for advanced non-small cell lung cancer on patients’ quality of life – a randomized controlled trial. Lung Cancer 53: 231-239, 2006
  14. Trippoli S, Vaiani M, Lucioni C, Messori A. Quality of life and utility in patients with non-small cell lung cancer. Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics. Pharmacoeconomics 19: 855-863, 2001
  15. Chouaid C, Agulnik J, Goker E, et al. Health-related q